Published
Cancer therapy resistance is a major challenge in oncology. This video explores the role of KRT17, a key driver of resistance across multiple cancer types. Learn how KRT17 contributes to drug resistance, its mechanisms, and emerging therapeutic strategies to overcome this critical issue. Discover the latest research and clinical implications for personalized cancer treatment.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
10:01
KRT17: The Hidden Protein Driving Cancer Therapy Resistance Explained
-
08:59
Novel Therapies And New Emerging LDL Cholesterol Lowering Strategies - (Part 01/06) (PCS CWS-2025)
-
04:31
Emerging strategies for unresectable or advanced hepatocellular carcinoma
-
08:49
KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target
-
04:06
Mechanisms of resistance to checkpoint inhibitors in head & neck cancer
-
07:29
Therapeutic Radiopharmaceuticals in Prostate Cancer: What the Urologist Needs to Know
-
06:46
KRT17: Unlocking Cancer Therapy Resistance and Emerging Therapeutic Strategies
-
05:24
Unlocking Cancer Treatment: Radiation Therapy Revealed | Yashoda Hospitals Hyderabad
-
08:09
KRT17: Unlocking the Mystery of Cancer Therapy Resistance
-
05:21
Precision Oncology: Unlocking the Power of Robotic Surgery and Radiation Therapy
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
